AMT-676 is under clinical development by Multitude therapeutics and currently in Phase I for Neuroendocrine Tumors.

PF-07921585 is under clinical development by Pfizer and currently in Phase I for Metastatic Colorectal Cancer.

Copper demand is expected to stay red-hot, according to Jorge Cantallopts, an executive director at the Center for Copper and ...

VERSES AI Inc. (CBOE:VERS) (OTCQB:VRSSF) ("VERSES'' or the "Company”), a cognitive computing company specializing in next generation intelligent systems, provides a corporate update. “Our mission is ...

VERSES AI Inc. (CBOE:VERS) (OTCQB:VRSSF) ("VERSES' or the "Company"), a cognitive computing company specializing in next generation intelligent ...

The success or failure of this transition hinges on the results of ... the target is “3 percent or higher.” “To ensure a phase change in the domestic economy and society, we will aim for ...

Moderna/Merck partnership and its potential in personalised cancer therapies are good opportunities for long-term investors.

Liverpool’s new manager has openly acknowledged that his playing style is not worlds apart from his predecessor, Jurgen Klopp, which has made the transition from one to the other far smoother.

Pharmaceutical and biotech stocks may find it tough to outperform the market in the months ahead. That is the view of UBS ...

Signals from the incoming administration indicate a possible focus on policy pivots that they believe will result in a more ...

FROM year to year, your face may not seem to change much. But over 12 months, there’s an incredible range of subtle ...

As 2024 ends, India’s AI sector has transitioned from its experimentation stage to strategic adoption, primarily driven by ...